The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of Met-enkephalin-like material in the nucleus accumbens of freely moving rats

Journal of Neurochemistry

Volumn 67, Issue 3, 1996, Pages 1301-1308

  Daugé, Valérie ^a   Mauborgne, Annie ^b   Cesselin, François ^b   Fournié Zaluski, Marie Claude ^a   Roques, Bernard Pierre ^a  

^a Laboratoire de Pharmacochimie   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Dual peptidase inhibitor; Met enkephalin like material; Microdialysis; Motor activity; Nucleus accumbens

Indexed keywords

ENZYME INHIBITOR; METENKEPHALIN DERIVATIVE; N [3 [(2 AMINO 4 METHYLTHIO)BUTYLDITHIO] 2 BENZYLPROPIONYL]PHENYLALANINE BENZYL ESTER; OPIATE PEPTIDE; PEPTIDASE; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0029799253     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67031301.x     Document Type: Article

References (42)

1. Baamonde A., Daugé V., Ruiz-Gayo M., Fulga I. G., Turcaud S., Fournié-Zaluski M.-C., and Roques B.-P. (1992) Antidepressant-type effects of endogenous enkephalins protected by systemic RB101 are mediated by opioid ∂ and dopamine D1 receptor stimulation. Eur. J. Pharmacol. 216, 157-166.
2. Bourgoin S., Le Bars D., Artaud F., Clot A. M., Bouboutou R., Founié-Zaluski M.-C., Roques B.-P., Hamon M., and Cesselin F. (1986) Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of Met-enkephalin-like material from the rat spinal cord. J. Pharmacol. Exp. Ther. 238, 360-366.
3. Bourgoin S., Le Bars D., Clot A. M., Hamon M., and Cesselin F. (1988) Spontaneous and evoked release of Met-enkephalin-like material from the spinal cord and of arthritic rats in vivo. Pain 32, 107-114.
4. Calenco-Choukroun G., Daugé V., Gacel G., Féger J., and Roques B.-P. (1991) Opioid ∂ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area. Psychopharmacology (Berlin) 103, 493-502.
5. Cesselin F., Oliveras J. L., Bourgoin S., Sierralta F., Michelot R., Besson J. M., and Hamon M. (1982) Increased levels of Metenkephalin-like material in the CSF of anaesthetized cats after tooth pulp stimulation. Brain Res. 237, 325-338.
6. Craves F. B., Law P. Y., Hunt C. A., and Loh H. H. (1978) The metabolic disposition of radiolabeled enkephalins in vitro and in situ. J. Pharmacol. Exp. Ther. 206, 492-506.
7. Daugé V., Rossignol P., and Roques B.-P. (1988) Comparison of the behavioral effects induced by administration in rat nucleus accumbens or caudate nucleus of selective μ and ∂ opioid peptides or kelatorphan, an inhibitor of enkephalin-degrading enzymes. Psychopharmacology (Berlin) 96, 168-175.
8. 3H) methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sci. 21, 907-914.
9. Fournié-Zaluski M.-C., Chaillet P., Bouboutou R., Coulaud A., Chérot P., Waksman G., Costentin J., and Roques B.-P. (1984) Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Eur. J. Pharmacol. 102, 525-528.
10. Fournié-Zaluski M.-C., Coric P., Turcaud S., Lucas E., Noble F., Maldonado R., and Roques B.-P. (1992) Mixed-inhibitor-prodrug as a new approach towards systemically active inhibitors of enkephalin degrading enzymes. J. Med. Chem. 35, 2473-2481.
11. Gobaille S., Schmidt C., Cupo A., Herbrecht F., and Maitre M. (1994) Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxy-butyrate on cellular and extracellular methionine-enkephalin levels. Neuroscience 60, 637-648.
12. Groenewegen H. J., Berendse H. W., Meredith G. E., Haber S. N., Voorn P., Wolters J. G., and Lohman A. H. M. (1991) Functional anatomy of the ventral, limbic system-innervated striatum, in The Mesolimbic Dopamine System: From Motivation to Action (Willner P. and Scheel-Krüger J., eds), pp. 19-60. John Wiley and Sons, New York.
13. Haber S. N. and Nauta W. J. H. (1983) Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry. Neuroscience 9, 245-260.
14. Hooks M. S. and Kalivas P. W. (1995) The role of mesoaccumbenspallidal circuitry in novelty-induced behavioral activation. Neuroscience 64, 587-597.
15. Johansson O. and Hökfelt T. (1980) Nucleus accumbens: transmitter histochemistry with reference to peptide-containing neurons, in The Neurobiology of the Nucleus Accumbens (Chronister R. B. and De France J. F. eds), pp. 147-172. Haer Institute for Electrophysiological Research, Brunswick, Maine.
16. Kalivas P. W. and Richardson-Carlson R. (1986) Endogenous enkephalin modulation of dopamine neurons in the ventral tegmental area. Am. J. Physiol. 251, R243-R249.
17. Kalivas P. W., Sorg B. A., and Hooks M. S. (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4, 315-334.
18. Kerdelhué B., Palkovits M., Karteszi M., and Reinberg A. (1981) Circadian variations in substance P, luliberin (LH-RH) and thyroliberin (TRH) contents in hypothalamic and extrahypothalamic brain nuclei of adult male rats. Brain Res. 206, 405-413.
19. Koob G. F. (1992) Neuronal mechanisms of drug reinforcement. Ann. NY Acad. Sci. 654, 171-191.
20. Ladurelle N., Keller G., Roques B.-P., and Daugé V. (1993) Effects of CCK8 and of the CCKB selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens; a microdialysis study in freely moving rats. Brain Res. 628, 254-262.
21. LeMoal M. and Simon H. (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71, 155-234.
22. Maidment N. T., Brumbaugh D. R., Rudolph V. D., Erdelyi E., and Evans C. J. (1989) Microdialysis of endogenous opioid peptides from rat brain in vivo. Neuroscience 33, 549-557.
23. Maldonado R., Valverde O., Ducos B., Blommaert A. G., Fournié-Zaluski M.-C., and Roques B.-P. (1995) Inhibition of morphine withdrawal by the association of RB101, an inhibitor of enkephalin catabolism, and the CCKB antagonist, PD-134,308. Br. J. Pharmacol. 114, 1031-1039.
24. Mansour A., Lewis M. E., Khachaturian H., Akil H., and Watson S. J. (1986) Pharmacological and anatomical evidence of selective μ, ∂ and κ opioid receptor binding in rat brain. Brain Res. 399, 69-79.
25. Meucci E., Delay-Goyet P., Roques B.-P., and Zajac J. M. (1989) Binding in vivo of selective μ and ∂ opioid agonists: opioid receptor occupancy by endogenous enkephalins. Eur. J. Pharmacol. 171, 176-178.
26. Naber D., Wirz-Justice A., and Kafka M. S. (1981) Circadian rhythm in rat brain opiate receptor. Neurosci. Lett. 21, 45-50.
27. Noble F., Soleilhac J., Soroca-Lucas E., Turcaud S., Fournié-Zaluski M.-C., and Roques B.-P. (1992a) Inhibition of enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB101 induces potent analgesic responses in mice and rats. J. Pharmacol. Exp. Ther. 261, 181-190.
28. Noble F., Coric P., Fournié-Zaluski M.-C., and Roques B.-P. (1992b) Lack of physical dependence in mice after repeated systemic administration of mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101. Eur. J. Pharmacol. 223, 91-96.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coodinates, 2nd edit. Academic Press, New York.
30. Robinson T. E. and Whishaw I. Q. (1988) Normalization of extracellular dopamine in the striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450, 209-224.
31. Roques B.-P., Daugé V., Gacel G., and Fournié-Zaluski M.-C. (1985) Selective agonists and antagonists of delta opioid receptors and inhibitors of enkephalin metabolism. Potential use in treatment of mental illness. Biol. Psychiatry 7, 287-289.
32. Roques B.-P., Noble F., Daugé V., Fournié-Zaluski M.-C., and Beaumont A. (1993) Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45, 87-146.
33. 3H]-diprenorphin binding. Brain Res. 571, 306-312.
34. Salamone J. D. (1991) Behavioral pharmacology of dopamine systems: a new synthesis, in The Mesolimbic Dopamine System: From Motivation to Action (Willner P. and Scheel-Krüger J., eds), pp. 599-613. John Wiley & Sons, New York.
35. Schade R., Vick K., Ott T., Sohr R., Pfister C., Bellach J., Golr G., and Lemmer B. (1995) Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats. Influence on dopaminergic stimulation. Chronobiol. Int. 12, 87-99.
36. Smith A. D., Olson R. J., and Justice J. B. Jr. (1992) Quantitative microdialysis of dopamine in the striatum: effect of circadian rhythm. J. Neurosci. Methods 44, 33-41.
37. Tempel A. and Zukin R. S. (1987) Neuroanatomical patterns of the μ, ∂ and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. USA 84, 4308-4312.
38. Valverde O., Fournié-Zaluski M.-C., Roques B.-P., and Maldonado R. (1996) The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology (Berlin) 123, 119-126.
39. Waksman G., Hamel E., Fournié-Zaluski M.-C., and Roques B.-P. (1986) Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of μ and ∂ opioid receptors in rat brain. Proc. Natl. Acad. Sci. USA 83, 1523-1527.
40. Wesche D. L. and Frederickson R. C. (1979) Diurnal differences in opioid peptide levels correlated with nociceptive sensitivity. Life Sci. 24, 1861-1868.
41. Wise R. A. and Bozarth M. A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.
42. Yaksh T. L. and Eide R. P. (1981) Factors governing release of methionine enkephalin-like immunoreactivity from mesencephalon and spinal cord of the cat in vivo. J. Neurophysiol. 46, 1056-1075.